Analyst Ratings For NASDAQ:UBX – Unity Biotechnology (NASDAQ:UBX)
Today, Citigroup initiated coverage on NASDAQ:UBX – Unity Biotechnology (NASDAQ:UBX) with a Buy with a price target of $32.00.
Some recent analyst ratings include
- 5/29/2018-Citigroup initiated coverage with a Buy rating.
- 5/29/2018-Morgan Stanley initiated coverage with a Overweight rating.
- 5/29/2018-Goldman Sachs Group initiated coverage with a Neutral rating.
Recent Trading Activity for NASDAQ:UBX – Unity Biotechnology (NASDAQ:UBX)
Shares of NASDAQ:UBX – Unity Biotechnology closed the previous trading session at 13.40 up +0.40 3.08% with 13.899999618530273 shares trading hands.